The Transfection Reagents Equipment Market size is expected to grow at an annual average of 6% during 2021-2027. Transfection is the process of producing genetically modified cells using foreign nucleic acids (DNA and RNA). This technology helps to regulate protein metabolism and gene therapy by influencing cancer cell mutation and nuclear genes in cells. Transfection is an essential instrument used in research studies on gene function and regulation of gene expression.
(Get 15% Discount on Buying this Report)
A full report of Transfection Reagents Equipment Market is available at: https://www.orionmarketreports.com/transfection-reagents-and-equipment-market/38271/ The following segmentation are covered in this report:
By Product
- Reagents
- Equipment
By End User
- Pharmaceutical & Biotechnology Companies
- Academics & Research Institutes
Company Profile
- Bio-Rad Laboratories, Inc.
- Lonza Group
- MaxCyte Inc.
- Merck KGaA
- Mirus Bio LLC
- Polyplus-transfection SA
- Promega Corporation
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Transfection Reagents Equipment Market
- The market share of the global Transfection Reagents Equipment Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Transfection Reagents Equipment Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Transfection Reagents Equipment Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
